Results from current clinical trials are rapidly evolving, with mixed results. In this EASL Studio the faculty discuss:

• why certain trials have failed whereas others have succeeded,
• what we have learned about the connection between overall survival and progression-free survival as endpoints, and
• how the systemic therapy of HCC has evolved.

Faculty

• Prof. Peter Galle (Moderator)
• Prof. Bruno Sangro (Faculty)
• Dr Anna Saborowski (Faculty)
• Prof. Arndt Vogel (Faculty)

Related episodes

• S2E15 – JHEP Live – The best animal model for HCC — lost in translation
• Special Edition: Highlights of the Liver Cancer Summit 2022
• Policy Dialogues Episode 3: Liver Cancer: The risk of ignorance

All EASL Studio Podcasts are available on EASL Campus.

In this episode of EASL Studio the experts discuss a non-cirrhotic portal vein thrombosis (PVT):

• What is PVT in the absence of cirrhosis,
• The role of interventional radiology in the management of portal cavernoma, and
• An update from the VALDIG portal Vein Thrombosis meeting

Faculty

• Prof. Pierre-Emmanuel Rautou (Moderator)
• Prof. Juan-Carlos Garcia-Pagan (Faculty)
• Dr Aurélie Plessier (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

As we near the end of 2022, this EASL Studio reflects upon:

• Which topics were most published about
• Which fields will we focus on in 2023
• What will the future of hepatology look like?

Faculty

• Prof. Paolo Angeli (Moderator)
• Prof. Jessica Zucman-Rossi (Moderator)
• Prof. Thomas Berg (Faculty)
• Prof. Aleksander Krag (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

Traditionally, journal impact factor has been the way to measure the impact of ones scientific articles. However, social media platforms are increasingly being used for the dissemination of publications. Join the faculty as they debate novel metrics to measure the impact of articles.

Faculty

• Prof. Jesus Banales (Moderator)
• Dr Atoosa Rabiee (Faculty)
• Dr Elliot Tapper (Faculty)
• Dr Juan Turnes (Faculty)

Related episode

• New era for science dissemination: The role of social media

All EASL Studio Podcasts are available on EASL Campus.

Antimicrobial resistance (AMR) is growing problem that greatly impacts treatment outcome. In this episode the faculty discuss:

• The impact of prescribing antibiotics as primary and secondary prophylaxis on AMR rates
• What can be done globally to reduce AMR rates

Faculty

• Prof. Debbie Shawcross (Moderator)
• Prof. Jonel Trebicka (Moderator)
• Prof. Jasmohan Bajaj (Faculty)
• Dr Lindsey Edwards (Faculty)
• Dr Benedikt Huttner (Faculty, WHO representative)

All EASL Studio Podcasts are available on EASL Campus.

Currently, the only established therapeutic option for end-stage liver disease is orthotopic liver transplantation. However, the paucity of donor organs limits this option to only a few patients. From liver stem cells to advanced tissue bioengineering, this episode of EASL Studio discusses regenerative hepatology techniques as an alternative treatment for patients.

Faculty

• Prof. Pedro Baptista (Moderator)
• Prof. Tobias Cantz (Faculty)
• Prof. Karen Piper Hanley (Faculty)
• Prof. Frederic Lemaigre (Faculty)

Related episode:

• YI Choice: Propelling liver cell biology into the third dimension

All EASL Studio Podcasts are available on EASL Campus.

In this JHEP Live the faculty discuss the use of antisense oligonucleotides and siRNAs in the treatment of chronic hepatitis B infections.

Faculty

• Prof. Joerg Petersen (Moderator)
• Prof. Maria Buti (Faculty)
• Prof. Man-Fung Yuen (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

Listen to this EASL Studio to find out:

• Which policies for prioritisation exist within a deceased donor liver allocation system?
• What is the impact of novel cancer therapies on the selection of patients with prior cancer?

Faculty

• Prof. Sherrie Bhoori (Moderator)
• Prof. Pål-Dag Line (Faculty)
• Prof. Vincenzo Mazzaferro (Faculty)
• Prof. Gonzalo Sapisochin (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

In recent years, the role of the gut microbiome in the development and severity of various diseases has come to light. In this episode, the experts examines:

• The role of microbiome in obesity.
• The role of microbiome in the transition from NAFLD to NASH.
• Practical solutions in microbiome medications.

Faculty

• Prof. Oren Shibolet (Moderator)
• Dr Aleksandra Kolodziejczyk (Faculty)
• Prof. Eran Elinav (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

In honour of World Hospice and Palliative Care Day (8 October), this EASL Studio episode examines:

• When is the best time to think about end-of-life care in liver disease?
• What does it mean for the liver care team?
• When and how should patients be referred to specialised palliative care?

Faculty

• Dr Patrizia Künzler-Heule (Moderator)
• Prof. Philip Larkin (Faculty)
• Dr Philip Berry (Faculty)

All EASL Studio Podcasts are available on EASL Campus.